Reversal of clonidine-induced hypotension by β-adrenoceptor blocking drugs (Q42240924)

19 October 2017

title

Reversal of clonidine-induced hypotension by beta-adrenoceptor blocking drugs (English)

1 reference

19 October 2017

Reversal of clonidine-induced hypotension by β-adrenoceptor blocking drugs (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

6 August 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

6 August 2023

author name string

H. L. Garvey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6105082

6 August 2023

B. L. Woodhouse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6105082

6 August 2023

language of work or name

English

0 references

publication date

1 July 1980

1 reference

19 October 2017

11 July 1980

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6105082

full work available at URL

6 August 2023

https://api.elsevier.com/content/article/PII:0014299980902083?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

https://api.elsevier.com/content/article/PII:0014299980902083?httpAccept=text/plain

6 August 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

European Journal of Pharmacology

6 August 2023

published in

1 reference

19 October 2017

volume

65

1 reference

19 October 2017

issue

1

1 reference

19 October 2017

page(s)

55-62

1 reference

Evidence for a central noradrenaline receptor stimulation by clonidine

19 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Clinical and clinical-experimental studies with a new blood pressure lowering substance: dichlorophenylaminoimidazoline

6 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system.

6 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

The antihypertensive effects of an imidazoline compound.

6 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

β-Adrenergic Receptors in the Central Nervous System of the Cat concerned with Control of Arterial Blood Pressure and Heart Rate

6 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Evidence for a central α-sympathomimetic action of Clonidine in the rat

6 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Sustained hypertension following the administration of desoxycorticosterone acetate

6 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

The paradox of beta-adrenergic blockade in hypertension

6 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Comparative antihypertensive effects and tissue distribution of beta adrenergic blocking drugs

6 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Centrally induced hypotensive effects of β-adrenergic blocking drugs

6 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

The central action of clonidine and its antagonism

6 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl.

6 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Some effects of propranolol on the central nervous system

6 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Reduction in sympathetic nervous activity as a mechanism for hypotensive effect of propranolol

6 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Effect of a new hypotensive drug, ST155, on the systemic circulation.

6 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Clonidine and the vasodilating beta blocker antihypertensive drug interaction

6 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

The use of clonidine and practolol in the treatment of hypertension

6 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Propranolol in hypertension

6 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Combination of clonidine and sotalol in hypertension

6 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Acute hypotensive action of 2-(2,6-dichlorophenylamino)- 2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery

6 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Localization of the hypotenisve effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan).

6 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan)

6 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

Hypotensive action of propranolol

6 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0014-2999(80)90208-3

6 August 2023

Identifiers

1 reference

19 October 2017

1 reference